Werfen's 60th Anniversary: Honoring Healthcare Professionals
In an extraordinary celebration of its six decades of service, Werfen has initiated a touching campaign titled "Thank You". The initiative aims to express gratitude towards healthcare professionals and laboratory teams whose dedicated work is vital in saving lives. The campaign's centerpiece is a short film featuring authentic testimonials from patients who emphasize the critical role of In-vitro Diagnostics (IVD) in medical decision-making.
The Importance of In-vitro Diagnostics
In today's medical landscape, In-vitro Diagnostics plays a pivotal role in approximately 70% of clinical decisions. From confirming compatibility during kidney transplants to diagnosing chronic diseases and monitoring patients during complex heart surgeries, IVD is essential for enhancing patient outcomes. Unfortunately, much of this complex analytical work occurs behind the scenes.
Through the "Thank You" initiative, Werfen hopes to bring the significance of reliable diagnostics into the spotlight. The documentary short film is available on Werfen's website and reveals the life-changing impacts of timely and accurate medical data. The campaign will also provide insights into how precise diagnostics contribute to better health management and improved quality of life for patients.
Real Stories from Real Patients
The campaign gathers heartfelt narratives from real patients who have traversed complex medical procedures. These stories highlight the immense appreciation patients have for medical professionals who analyzed their test results and guided them on the right therapeutic path. The initiative collaborates with patient associations and nonprofits to underscore the importance of diagnostic precision in treating over a dozen serious conditions, including lupus, thalassemia, hemophilia, and various transplant scenarios.
As Alejandro Risso, CEO of Werfen, articulated, "Werfen was founded sixty years ago to assist healthcare professionals during pivotal moments in patients' lives. Our mission is to ensure the highest analytical precision so that professionals can confidently make decisions when it matters most."
Celebrating 60 Years of Commitment
The launch of this campaign coincides with Werfen's 60th anniversary, marking a significant milestone for a company initially founded in Barcelona in 1966. Over the years, it has evolved into a multinational corporation specializing in IVD across over 30 countries. With research and development capabilities, and production facilities located in Europe and the United States, Werfen's commitment to innovation remains steadfast.
Throughout its history, Werfen has bolstered its international presence through commercial expansions into key markets, including the United States and China. In 2024, this commitment culminated in the strategic decision to concentrate all resources and research on In-vitro Diagnostics, ensuring that the scientific and medical communities have enhanced certainty in their work.
In 2025 alone, Werfen dedicated €190 million to research and development, fueling advancements in the science of In-vitro Diagnostics. In a world where scientific accuracy and reliability are crucial, Werfen blends innovation with experience to enhance diagnostic solutions, empowering hospitals and laboratories to make informed clinical decisions.
About Werfen
Founded in 1966, Werfen develops, manufactures, and distributes specialized diagnostic instruments, reagents, automation workstations, and data management solutions primarily utilized in hospitals and independent clinical laboratories. Their business segments include Hemostasis, Acute Diagnostics, Transfusion, Autoimmunity, and Transplantation. With over 7,130 employees, Werfen operates in more than 30 countries, directly and through distribution partners in over 100 regions. More details can be found on
werfen.com.